BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2017
View Archived Issues
Phase I study to compare safety and pharmacokinetics of NVP-1402 and NVP-1402R
Read More
Potent PI3Kdelta inhibitors for the treatment of inflammatory and autoimmune diseases
Read More
MicroQuin describes cancer candidates MQ-001 and MQ-002
Read More
RepliCel Life Sciences reports interim data from phase I study of RCS-01
Read More
FDA accepts for review sNDA seeking approval of ibrutinib in chronic GvHD
Read More
Bristol-Myers Squibb presents prodrug of BMT-1438 for the treatment of rheumatoid arthritis
Read More
DuPont announces business transaction agreement with FMC
Read More
Amgen seeks to expand current indication for Xgeva to include patients with multiple myeloma
Read More
BAY-1816032, a novel BUB1 inhibitor with potent antitumor activity
Read More
FDA grants priority review to sBLA for Opdivo in colorectal cancer
Read More
RedHill Biopharma's ABC-294640 receives FDA orphan drug designation for cholangiocarcinoma
Read More
Intralytix and BioPhage to develop topical bacteriophage treatment for S. aureus-infected wounds
Read More
Meiji Seika Pharma and Eisai sign licensing agreement for safinamide in Japan and Asia
Read More
Pharmacokinetics and pharmacodynamics of AG-B1512 in preclinical models reported
Read More
Evotec reaches first milestone in diabetes collaboration with Sanofi
Read More
Roche presents Toll-like receptor 8 agonists
Read More
Merck KGaA discloses ASIC1 inhibitors
Read More
QIAGEN obtains license to RNA biomarker from Johns Hopkins
Read More
Janssen Pharmaceuticals and collaborator divulge dengue virus replication inhibitors
Read More
BloodCenter of Wisconsin launches more precise VWF test in U.S.
Read More
Pharmascience discovers Tec family kinase inhibitors
Read More
AB Science identifies SYK kinase inhibitors
Read More
X4-136 in combination therapy with anti-PD-1 improves survival in murine ovarian cancer model
Read More
Phase I/II trial of a novel vaccine candidate AV-0328
Read More
NantKwest and Viracta Therapeutics close series B financing, enter partnership
Read More